How We Treat Cancer
Leveraging the Latest
Cancer Treatments
How We Treat
Cancer
Leveraging the
Latest Cancer
Treatments

How We Treat Cancer

At SCRI Oncology Partners, our patients benefit from a cancer treatment team that is led by internationally-recognized experts with decades of experience. Through our unique affiliations with Sarah Cannon Research Institute and The US Oncology Network, we provide patients access to state-of-the-art personalized care, new cancer treatment breakthroughs and opportunities to participate in innovative clinical trials – all without leaving Tennessee. We are here to support you from screening to survivorship and are dedicated to advancing care for all.

Transforming care

We strive to provide comprehensive cancer care to all patients – beginning at diagnosis, helping patients navigate primary treatment and post-treatment, in addition to addressing recurrence and symptom management.  Our treatments include chemotherapy, immunotherapy, targeted therapy, next-generation sequencing (NGS) and participation in clinical trials.  In addition we are proud to offer parallel support from our palliative care program open to all patients.

Chemotherapy

Chemotherapy, also known as “chemo,” is a type of cancer treatment that involves using medicines to destroy cancer cells and prevent them from multiplying and growing.  The specific medicines used, as well as their dosages and the length of treatment needed, vary from patient to patient and are carefully selected to ensure efficacy and safety. While most people receive chemotherapy intravenously through an IV, it is also possible to receive chemo as an injection, orally or topically.  Chemotherapy specifically targets fast-growing cells, like cancer, and has been an effective cancer treatment for decades – especially when used in conjunction with other treatments.

Learn more

Immunotherapies

Immunotherapy is a cancer treatment that utilizes your body’s natural defenses in order to seek out and destroy cancer cells.  It is a common initial treatment for cancers that have spread from its original location to other parts of the body, also called metastatic cancer, and is often used in combination with chemotherapy or other cancer treatments. Immunotherapy types include the use of checkpoint inhibitors, adoptive cell therapy, monoclonal antibodies and immune system modulators, among others. Immunotherapy includes new cancer treatment breakthroughs that have been shown to be very effective and help some people with cancer live longer.

Learn more

Clinical trials

Clinical trials are the cornerstone of research advancements. A clinical trial is a voluntary medical research study that tests new ways to prevent, screen, diagnose or treat a disease. Cancer clinical trials help determine if a treatment, drug or procedure shows a better way of treating a particular cancer or condition. Clinical trials are crucial for understanding how patients respond to therapies and help pave the way for new care options.  In the past, patients were generally only able to access clinical trials at large academic medical centers, but SCRI Oncology Partners is dedicated to bringing clinical trials and the latest cancer treatments to the communities here in Tennessee.  By participating in clinical trials, you can access new treatments and therapies while also helping our oncology experts develop new medications and treatment strategies for others facing cancer.

Learn more

Targeted therapies and next-generation sequencing

In the last decade, cancer research has rapidly expanded the list of cancer biomarkers with associated targeted therapies. Next-generation sequencing (NGS), also known as massively parallel sequencing, is a tool used by oncologists to determine a cancer’s biomarkers and decide on the best treatment for a specific patient. After taking a biopsy or blood sample, NGS allows clinicians to test those samples for mutations and biomarkers rapidly by testing many genes of a cancer simultaneously—saving time, money, and the need for additional tissue samples.  Next-generation sequencing is recommended for patients that have a cancer that commonly includes several molecular targets, and for which multiple tests might otherwise be necessary. If a target is identified, patients are often a candidate for a therapy that specifically targets the mutations on the cancer cell while sparing healthy cells. These can often be very effective and can spare many of the traditional side effects of chemotherapy.

Learn more

Palliative care services

While we will help you through all aspects of care following a cancer diagnosis, palliative care specifically focuses on the variety of aspects that “coping with cancer” encompass for you. For many cancer patients, whether as a result of the cancer itself or the accompanying treatment regimen, there are aspects of care which bring heightened degrees of discomfort, anxiety or fear. Palliative care involves a customized approach toward managing your symptoms and is an important part of many patients’ treatment plans, regardless of prognosis. Helping you reach an understanding of your condition, ensure signs and symptoms are managed effectively, while preserving quality of life whatever that means for you.

We’re here to help, discover more resources

Six Must-Knows about Bladder Cancer

Six Must-Knows about Bladder Cancer

Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.

What is Metastatic Breast Cancer?

What is Metastatic Breast Cancer?

Metastatic breast cancer is breast cancer that has spread from the breast to other parts of the body. This is also referred to as advanced or stage 4 breast cancer.

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact us

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact us